Black Maple Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Black Maple Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,000	Closed	-$307K	–	131
2023 Q2	$307K	Buy	+8,000	New	+$205K	0.18%	62

Black Maple Capital Management's KDNY Position: Q3 2023 in Review

Black Maple Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 8,000 shares — an estimated $307K sold.

Black Maple Capital Management first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $307K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Black Maple Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Black Maple Capital Management sold 8,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $307K.
Black Maple Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Black Maple Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $307K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Black Maple Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.